Dr. John B. Wong

Dr. John B. Wong

Vice Chair of Academic Affairs in the Department of Medicine, Member of the USPSTF Task Force

Vice Chair of Academic Affairs in the Department of Medicine, Member of the USPSTF Task Force

Tufts Medical Center

John B Wong, MD is a primary care general internist and Vice Chair of Academic Affairs in the Department of Medicine at Tufts Medical Center and a Professor of Medicine at the Tufts University School of Medicine. He is a member of the US Preventive Services Task Force, a Master of the American College of Physicians, a past president of the Society for Medical Decision Making, and an Associate Statistical Editor at the Annals of Internal Medicine. His research focuses on the application of decision analysis to help patients, clinicians, and policymakers choose among alternative tests, treatments or policies, thereby promoting rational evidence-based efficient and effective patient-centered care that reflects individualized risk assessment and patient preferences. He received his BS with honors from Haverford College and MD from the University of Chicago and completed residency and medical informatics fellowship in Clinical Decision Making in Internal Medicine at Tufts Medical Center.

Congressman Gregory Meeks

Congressman Gregory Meeks

U.S. House of Representatives

U.S. House of Representatives

New York D-5

From public housing to the nation’s Capital, Gregory Weldon Meeks has lived a true American success story. Known for his compassionate and tenacious representation of his constituents, and his coalition-building skills, Meeks proudly serves the constituents of New York’s Fifth Congressional District in the U.S. House of Representatives

Dr. Curtis A. Pettaway

Dr. Curtis A. Pettaway

Professor, Department of Urology

Professor, Department of Urology

MD Anderson Cancer Center

Dr. Curtis Pettaway is a Professor of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas. His clinical practice is based on treating patients with genitourinary malignancies, including penile, urethral, and prostate malignancies. The goals of his prostate-related studies are to further define the host and molecular markers of cancer progression and to reduce disparities in prostate cancer outcomes among African Americans and the underserved by studying both the clinical and biological correlates of aggressive disease.

He has served as the Medical Director of the Prostate Outreach Project (POP), an initiative that has educated and screened more than 5,000 men. Dr. Pettaway has also served as the Co-Director of a National Cancer Institute-funded study evaluating the influence of West African ancestry on the incidence and aggressiveness of prostate cancer among African American and Puerto Rican populations.

Dr. Daniel Barocas

Dr. Daniel Barocas

Professor, Department of Urology

Professor, Department of Urology

Vanderbilt University Medical Center

Dr. Daniel Barocas is an accomplished researcher who focuses on quality of life, quality of care, healthcare disparities, and comparative effectiveness. He is the principal investigator of a multi-center study on the effectiveness and side effects of different treatments for prostate cancer.

Dr. Simpa Salami

Dr. Simpa Salami

Assistant Professor, Urology

Assistant Professor, Urology

University of Michigan Health Michigan Medicine

Simpa S. Salami, M.D., M.P.H., is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his MD from the College of Medicine, University of Ibadan, Nigeria. He completed a Master of Public Health program at Harvard University, a General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and a Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami is a translational surgeon-scientist whose research interests are in early detection and staging of prostate and kidney cancer. The goal of his research is to develop novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response.  Dr. Salami is a recipient of numerous awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, and Society of Urologic Oncology Young Investigator Awards. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation.

Dr. Yaw Nyame

Dr. Yaw Nyame

Assistant Professor and OCOE Program Lead, Department of Urology

Assistant Professor and OCOE Program Lead, Department of Urology

Fred Hutchinson Cancer Center, University of Washington

Dr. Yaw Nyame attended medical school at the Feinberg School of Medicine at Northwestern University and business school at the Kellogg School of Management at Northwestern University, graduating in 2012. Prior to medical school, he completed a Master’s Degree in Health Services and Administration at the School of Public Health at George Washington University.

Dr. Nyame completed his general surgery internship and urology residency training at the Glickman Urological and Kidney Institute at the Cleveland Clinic. He came to the Northwest to complete a Society of Urologic Oncology accredited fellowship at the University of Washington and joined the faculty upon completing his training.

Dr. Nyame has a research interest in health disparities in urologic cancers with a focus on using patient-centered approaches to build translational health services as well as molecular and clinical solutions to health inequities in prostate cancer and other urologic malignancies.